The SEC announced charges against Pennsylvania-based pharmaceutical company Mylan N.V. for accounting and disclosure failures rel...
CN Editor
September 30, 2019
CLINICAL TRIAL RESULTS DROVE INSIDER TRADING: SEC
SEC DROPS ACCOUNTING FRAUD CASE AGAINST MINING EXEC
SEC PUBLISHES STAFF REPORT ON CAPITAL-RAISING DYNAMICS
SEC PROPOSES AMENDMENTS TO THE SMALL ENTITY DEFINITIONS FOR INVESTMENT COMPANIES AND INVESTMENT ADVISERS FOR PURPOSES OF THE REGULATORY FLEXIBILITY ACT
Thank you for the feedback!!
2026 COMPLIANCE PRIORITIES AND REGULATORY DIVISION INITIATIVES
THE BANKER, THE BROTHERS, THE FRIENDS AND THEIR FRAUDS
DRAMATIC INCREASE IN FINTRAC FINES COMING, BUT THEIR EFFECTIVENESS IS LESS CLEAR
CIRO SANCTIONS FORMER RBC DOMINION SECURITIES REP FROM ONTARIO